Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Curanex Pharmaceuticals Inc (CURX) had Free Cash Flow per Share of $-0.41 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.07M |
|
$-3.07M |
|
-- |
|
-- |
|
$0.03M |
|
25.50M |
|
25.50M |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$11.23M |
|
-- |
|
$0.35M |
|
$11.58M |
|
$0.14M |
|
-- |
|
$0.22M |
|
$0.36M |
|
$11.22M |
|
$11.22M |
|
$11.22M |
|
28.34M |
|
| Cash Flow Statement Financials | |
$-10.48M |
|
-- |
|
$15.31M |
|
$0.15M |
|
$4.97M |
|
$4.82M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
81.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.39% |
|
-27.39% |
|
-26.53% |
|
-27.39% |
|
$0.40 |
|
|
Free Cash Flow per Share |
$-0.41 |
$-0.41 |
|